Adverse treatment effects Prednisolone (systemic) MMF IVIG Rituximab   Azathioprine Total Patient Cases
Sleep Disturbance 3         3
Increased appetite 4         4
Weight gain 3         3
Increased BSLs 2         2
Lethargy 3 1       4
Agitation/irritability 2         2
Osteopaenia/osteoporosis 9         9
Lymphopaenia 1       1* 2
Oral candidiasis 7         7
Spontaneous Ecchymoses 2         2
Gastric upset (nausea/vomiting/diarrhoea) 3 4       7
Flare of infection (orchitis, CMV, HSV) 4 4       1 9
Flare of Acne 1         1
LFT derangement   2       2
Shortness of Breath 1 1       2
Cushingoidfacies 5         5
Post inflammatory hyperpigmentation 3 4   1   8
Patient perceived effects (discomfort/distress) 2 2       4
Unaffordability       1   1
Total side effect cases for each treatment 55 20   2   77
Total patients (receiving  treatment for pemphigus vulgaris) 21 (n) 17 2 7    
  n= total sample of patients with biopsy proven pemphigus vulgaris
*severe life threatening lymphopaenia (<0.2) with reduced T- cell subsets (CD4 and CD8 counts) for single case of MMF tx    
Table 1: Distribution of adverse treatment effects encountered on most common systemic therapies for the management of Pemphigus Vulgaris.